Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
6.02
+0.22 (3.79%)
Sep 20, 2024, 4:00 PM EDT - Market closed
Abeona Therapeutics Employees
Abeona Therapeutics had 84 employees as of December 31, 2023. The number of employees increased by 27 or 47.37% compared to the previous year.
Employees
84
Change (1Y)
27
Growth (1Y)
47.37%
Revenue / Employee
n/a
Profits / Employee
-$626,179
Market Cap
260.75M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Inogen | 834 |
Adaptimmune Therapeutics | 449 |
Amarin Corporation | 275 |
2seventy bio | 274 |
Inhibrx Biosciences | 172 |
Nanobiotix | 102 |
XBiotech | 82 |
Candel Therapeutics | 42 |
ABEO News
- 17 days ago - Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 18 days ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors - GlobeNewsWire
- 5 weeks ago - Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel - GlobeNewsWire
- 5 weeks ago - Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission - GlobeNewsWire
- 2 months ago - Abeona: BLA Resubmission Of Pz-Cel Gets Ball Rolling Towards Other Milestones - Seeking Alpha
- 2 months ago - Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications - GlobeNewsWire
- 2 months ago - Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum - GlobeNewsWire